Associate Professor Steven Tong

Principal research fellow

Qualifications:

PhD, Charles Darwin University, 2010; Bachelor of Medicine and Bachelor of Surgery with Honours, University of Melbourne, 1998; Fellow Royal Australasian College of Physicians, 2006; Graduate Diploma Clinical Epidemiology, Newcastle University, 2010.

Approved level of HDR supervision at Charles Darwin University:

Associate Supervisor for PhD

Location:

Darwin - Royal Darwin Hospital campus

Biography:

Associate Professor Tong is an infectious diseases physician with research interests in infectious diseases affecting Indigenous people. He aims to combine clinical epidemiology with molecular genetic approaches to better understand the patterns and transmission of diseases due to agents such as Staphylococcus aureus, hepatitis B, and influenza.

He was the inaugural Northern Territory Fulbright Scholar and trained at Duke University, North Carolina in 2011. He was also a visiting scientist at the Wellcome Trust Sanger Institute for all of 2012.

He has established numerous collaborations with overseas laboratories as well as fellow clinician-researchers in Australia. He is currently co-leading an international multicentre randomised controlled trial of combination therapy for S. aureus bloodstream infections.

  1. Bowen, A.C., Harris, T., Holt, D.C., Giffard, P.M., Carapetis, J.R., Campbell, P.T., McVernon, J., & Tong, S.Y.C. (2016). Whole genome sequencing reveals extensive community-level transmission of group A Streptococcus in remote communities. Epidemiology Infections, 144, 1991-8.
  2. Andersson, P., Harris, S.R., Seth-Smtih, H.M.B., Hadfield, J., O’Neill, C., Cutcliffe, L.T., et al. (2016). Chlamydia trachomatis isolates from Australian Aboriginal people with trachoma form distinct lineages. Nature Communications, 7,10688.
  3. Clemens, E.B., Grant, E.J., Wang, Z., Gras, S., Tipping, P., Rossjohn, J.,et al. (2016). Towards identification of immune and genetic correlates of severe influenza disease in Indigenous Australians. Immunology Cell Biology, 94, 367-77.
  4. Davis, J.S, Sud, A., O’Sullivan, M.V.N., Robinson, J.O., Ferguson, P.E., Foo, H., et al. (2016). Combination of vancomycin and β-lactam therapy for methicillin-resistant Staphylococcus aureus bacteremia: A pilot multicenter randomized controlled trial. Clinical Infectious Diseases, 62, 173-80.
  5. Tong, S.Y.C., Davis, J.S., Eichenberger, E., Holland, T.,&  Fowler, V.G. (2015). Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management. Clinical Microbiology Reviews, 28, 603-61.
  6. Tong, S.Y.C., Holden, M.T.G., Nickerson, E.K., Cooper, B.S., Köser, C.U., Cori, A., et al. (2015). Genome sequencing defines phylogeny and spread of methicillin-resistant Staphylococcus aureus in a high transmission setting. Genome Research, 25,111–8.
  7. Tong, S.Y.C., Schaumburg, F., Ellington, M.J., Corander, J., Pichon, B., Leendertz, F., et al. (2015). Novel staphylococcal species that form part of a Staphylococcus aureus related complex: the non-pigmented S. argenteus sp. nov. and the non-human primate associated S. schweitzeri sp. nov. International Journal of Systematic and Evolutionary Microbiology, 65, 15-22.
  8. Bowen, A.C., Tong, S.Y.C., Andrews, R.M., O'Meara, I.M., McDonald, M.I., Chatfield, M.D., Currie, B.J., & Carapetis, J.R. (2014). Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial. Lancet, 384, 2132-40.
  9. Davies, J., Littlejohn, M., Locarnini, S.A., Whiting, S., Hajkowicz, K., Cowie, B.C., Bowden, D.S., Tong, S.Y., & Davis, J.S. (2013). .The molecular epidemiology of hepatitis B in the Indigenous people of northern Australia. Journal of Gastroenterology and Hepatology Foundation28, 1234-41.
  10. Flint, S.M., Davis, J.S., Su, J.-Y., Oliver-Landry, E.P., Rogers, B.A., Goldstein, A., et al. (2010). Disproportionate impact of pandemic (H1N1) 2009 influenza on Indigenous people in the Top End of Australia’s Northern Territory. Medical Journal of Australia, 192, 1-6.
  1. The winner takes it all  for S. aureus

    The winner takes it all for S. aureus

    Date

    The CAMERA2 study, executed in multiple countries addressing the question whether addition of a beta-lactam antibiotic (7 days) improves outcome in patients with MRSA bacteremia.

  2. Two New Trials of Combination Therapy for MRSA Bacteremia

    Two New Trials of Combination Therapy for MRSA Bacteremia

    Date

    The CAMERA2 study, just presented by Steven Tong at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

  3. Contagion® to Report on the ECCMID Conference in Amsterdam

    Contagion® to Report on the ECCMID Conference in Amsterdam

    Date

    Steven Y. C. Tong, PhD, with the Menzies School of Health Research in Darwin, Australia, will speak about the results of the CAMERA2 trial on combination antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteremia.

  4. CAAMA Podcast | Strong Voices Monday 25/09/2019

    CAAMA Podcast | Strong Voices Monday 25/09/2019

    Date

    Australian researchers have used current Hepatitis B virus genome sequences to map the movement of Aboriginal people into Australia. A senior research fellow at the Menzies school of health research discusses the research paper.

  5. Hepatitis B DNA Helps Trace History and Movement of First Australians

    Hepatitis B DNA Helps Trace History and Movement of First Australians

    Date

    The team found that hepatitis B virus isolated from these Aboriginal Australians is a unique strain called HBV/C4, which is not found anywhere else in the world.

  6. Hepatitis B virus sheds light on ancient human population movements

    Hepatitis B virus sheds light on ancient human population movements

    Date

    LongRoom News | Australian researchers have used current hepatitis B virus (HBV) genome sequences to deduce ancient human population movements into Australia.

  7. Hepatitis B virus sheds light on ancient human population movements

    Hepatitis B virus sheds light on ancient human population movements

    Date

    LongRoom News | Australian researchers have used current hepatitis B virus (HBV) genome sequences to deduce ancient human population movements into Australia.

  8. Hepatitis B virus sheds light on ancient human population movements into Australia

    Hepatitis B virus sheds light on ancient human population movements into Australia

    Date

    Australian researchers have used current hepatitis B virus (HBV) genome sequences to deduce ancient human population movements into Australia, adding weight to the theory that the mainland Aboriginal population separated from other early humans at least 59 thousand years ago and possibly entered the country near the Tiwi Islands.

  9. Eliminating skin disease in Aboriginal children could reduce antibiotic use by almost 20%

    Eliminating skin disease in Aboriginal children could reduce antibiotic use by almost 20%

    Date

    A study has revealed that 95 per cent of children in five remote Aboriginal communities had received an antibiotic prescription before their first birthday and almost half of them had received up to six prescriptions.

  10. Building genomics expertise in the NT

    Building genomics expertise in the NT

    Date

    Menzies is investing and developing expertise in the emerging research area of genome sequencing. In the past year, we took the lead in a number of national and international collaborative programs investigating the genomics of tropical pathogens, and...

  11. Bendigo Advertiser | Pain free staph fix given green light

    Bendigo Advertiser | Pain free staph fix given green light

    Date

    Menzies School of Health Research (Menzies), findings show there has been inaccurate reporting of resistance to the recommended antibiotic, trimethoprim- sulfamethoxazole (Bactrim).

  12. Pain free golden staph treatment cleared for use in remote communities

    Pain free golden staph treatment cleared for use in remote communities

    Date

    A northern Australian research team has provided reassuring support for the continued use of an oral treatment option for patients with skin infections, finding that there has been inaccurate reporting of resistance to the recommended antibiotic.

  13. National Healthy Skin Guideline

    National Healthy Skin Guideline

    Date

  14. Developing Northern Australia 2017 Implementation Report

    Developing Northern Australia 2017 Implementation Report

    Date

    Page 20 - Case Study | The Australian Government funded HOT NORTH project has hit the ground running in 2017, and is building north Australia’s expertise and capacity in tropical medicine through research projects that will transfer new knowledge to communities.

  15. E-news Healthy Tomorrow - Hot North Pilot Projects

    E-news Healthy Tomorrow - Hot North Pilot Projects

    Date

    The first six pilot projects have been funded to help close critical gaps in health outcomes in northern Australia and the Asia-Pacific region as part of the unique collaborative program Improving Health Outcomes in the Tropical North (HOT NORTH), led by Menzies. Twelve pilot projects per year will be supported by HOT NORTH.

  16. Associate Professor Steven Tong honoured with Frank Fenner Award

    Associate Professor Steven Tong honoured with Frank Fenner Award

    Date

    Associate Professor Steven Tong, Infectious Diseases Physician at the Royal Melbourne Hospital and Indigenous Health Theme Leader at the Peter Doherty Institute for Infection and Immunity (Doherty Institute), has been awarded the 2017 Frank Fenner Award for Advanced Research in Infectious Diseases.

  17. Defeating serious MRSA infections using an everyday drug that shouldn’t work

    Defeating serious MRSA infections using an everyday drug that shouldn’t work

    Date

    A new drug combination is the first step towards improving treatment of drug resistant golden staph (MRSA) - a breakthrough that could potentially save hundreds of lives, every day.

  18. A new strain of Hepatitis B found in the Northern Territory

    A new strain of Hepatitis B found in the Northern Territory

    Date

    Researchers say a unique strain of Hepatitis B found only in the Northern Territory could be a main contributor to the high rates of liver cancer found in Aboriginal people.

  19. ‘Golden staph’ three species, not one

    ‘Golden staph’ three species, not one

    Date

    'Stories of Australian Science' magazine

  20. Researchers discover a new silver species of Staphylococcus

    Researchers discover a new silver species of Staphylococcus

    Date

    Scientists from a pioneering Northern Territory-based research project have uncovered two new species of staphylococcus. One of the two has been officially registered as Staphylococcus argenteus, or more commonly Silver Staph.

  21. Research reveals alarmingly high rates of the world’s second most deadly cancer in the NT

    Research reveals alarmingly high rates of the world’s second most deadly cancer in the NT

    Date

    A new study conducted by Menzies has found a very high prevalence of liver cancer in the NT.

  22. Pioneering skin sores research to improve health of children globally

    Pioneering skin sores research to improve health of children globally

    Date

    A NT-based research project investigating alternative and more practical treatments for skin sores is set to benefit the millions of children worldwide who suffer from this infection.

  23. NHMRC project snapshot: Dr Steve Tong

    NHMRC project snapshot: Dr Steve Tong

    Date

    Menzies' Post-doctoral Research Fellow Dr Steve Tong was recently awarded a competitive grant and a fellowship as part of the National Health and Medical Research Council's yearly multi-million dollar funding round.

  24. NHMRC fellowship snapshot: Dr Steve Tong

    NHMRC fellowship snapshot: Dr Steve Tong

    Date

    Menzies' Post-doctoral Research Fellow Dr Steve Tong was recently awarded a competitive grant and a fellowship as part of the National Health and Medical Research Council's yearly multi-million dollar funding round.

  25. Developing global links in the fight against a super-bug

    Developing global links in the fight against a super-bug

    Date

    For years it's been the super-bug in hospitals around Australia. Golden staph, or Staphylococcus aureus, is resistant to a wide range of antibiotics, difficult to treat and seemingly impossible to eradicate. Golden staph is one of the most aggressive...

  26. 2011 Fulbright Northern Territory Scholar

    2011 Fulbright Northern Territory Scholar

    Date

    Menzies researcher Dr Steven Tong has been awarded a prestigious Fulbright Scholarship for his critical research into golden staph, a major cause of severe community and hospital acquired infections.